Monument Therapeutics
Monument Therapeutics is a psychiatric drug developer for schizophrenia treatment founded in 2019 by Jenny Barnett .
CFO
Company Operating Status
Active
Country
Date Incorporated
January 31, 2019
Email Address
info@monumenttx.com
Founded Date
January 31, 2019
Founder
Full Address
Tunbridge Court Tunbridge Lane, Bottisham, Cambridge, United Kingdom, CB25 9TU
Incorporation Reference
11798829
Latest Funding Round Date
February 25, 2025
Latest Funding Round Amount (USD)
1,100,000
Latest Funding Type
Legal classification
LinkedIn URL
Location
Number of Employees (Ranges)
1 – 10
Total Funding Amount (USD)
2,400,000
UKSIC Code
72110
Official Website
Find more companies like Monument Therapeutics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.